Loading...
Search for:
valeric-acid
0.005 seconds
Designing highly stable yet efficient solar cells based on a new triple-cation quasi-2D/3D hybrid perovskites family
, Article Ceramics International ; Volume 45, Issue 16 , 2019 , Pages 20788-20795 ; 02728842 (ISSN) ; Abdizadeh, H ; Mirhosseini, M ; Taghavinia, N ; Sharif University of Technology
Elsevier Ltd
2019
Abstract
In a nutshell, this study outlines the efficacy of mixed dimensional (2D/3D) hybrid perovskites by developing a new class of triple-cation quasi-2D perovskites having (S0.97S′0.03)2[Cs0.05(FA0.97MA0.03)0.95]n-1Pbn(I0.07Br0.03)3n+1 general composition, in which a mixture of ý5-ammonium valeric acid ýiodideý (S) and tetra-n-octylammonium ýbromide (S′) was employed ýas a spacer.ý The effect of the 2D and 3D structures molar ratios (i.e., C=2D/2D+3D) in the range of 0-100 % on photovoltaic performance of the deposited photoanodes was systemically studied. Drawing a comparison between such compounds and an analogous triple-cation 3D counterpart (i.e., Cs0.05(FA0.83MA0.17)0.95Pb(I0.83Br0.17)3) as...
A pilot study of the effect of phospholipid curcumin on serum metabolomic profile in patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial
, Article European Journal of Clinical Nutrition ; Volume 73, Issue 9 , 2019 , Pages 1224-1235 ; 09543007 (ISSN) ; Mirhafez, S. R ; Dehabeh, M ; Hariri, M ; Azimi Nezhad, M ; Nobakht M. Gh, B. F ; Sharif University of Technology
Nature Publishing Group
2019
Abstract
Background/Objectives: Curcumin, a natural polyphenol compound in the spice turmeric, has been found to have potent anti-oxidative and anti-inflammatory activity. Curcumin may treat non-alcoholic fatty liver disease (NAFLD) through its beneficial effects on biomarkers of oxidative stress (OS) and inflammation, which are considered as two feature of this disease. However, the effects of curcumin on NAFLD have been remained poorly understood. This investigation evaluated the effects of administrating curcumin on metabolic status in NAFLD patients. Subjects/Methods: Fifty-eight NAFLD patients participated in a randomized, double-blind, placebo-controlled parallel design of study. The subjects...